(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CETSA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

CETSA

ST13

US500000079173127

Class

1, 5, 42

Filing

79173127

Registration

4948669

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

51

Latest update

08/12/2026

Classification

Registered

Trademark type

Word

Nice classes

1, 5, 42

Filing date

06/19/2015

Registration date

05/03/2016

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/12/2026

Last transaction

08/12/2026

Responsible office

United States Patent and Trademark Office

Status code

707

Official register

Principal Register

Drawing code

4

Owner type

16

Owner location

Solna, SE

Examiner

POLZER, NATALIE M

Current location

Historical data usage

Holders and representatives

Holders

Pelago Bioscience AB
Pelago Bioscience AB

Representatives

Garth M. Dahlen MENDELSOHN DUNLEAVY P.C.

Technical classification

Nice Classes

Class 1Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical preparations for use in science * other than for medical or veterinary use; * biochemicals for in vitro and in vivo for scientific use; biological tissue cultures other than for medical or veterinary purposes; diagnostic preparations for scientific or research use; in-vivo diagnostic reagents scientific use; antibodies for in vitro research use; antibodies for in vitro scientific use; reagents for scientific purposes; chemical substanceschemicals for scientific laboratory use; testing reagents for scientific use; universal reagents for automated test systems for scientific or laboratory research use; universal reagents for automated test systems for scientific use; chemical substanceschemicals for scientific use; enzymes for scientific purposes; enzymesother than for medical useused in detecting proteins; proteins in raw material form for use in science; protein in raw material form for scientific and medical research; chemical substanceschemicals for impregnation into membranes to separate proteins from liquids

Class 5

Diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic testing materialsagentspreparations and substances for medical use; diagnostic reagents for medical use; diagnostic indicatorsprotein arrays for medical diagnosis; chemical reagents for medical or veterinary purposes; chemical test reagents for medical purposes; chemical test reagents for veterinary purposes chemical test reagents veterinary; reagents for medical analytical purposes; reagents for use in medical analysis; reagents for medical in-vitro laboratory use

Class 42

Services of a chemical and/or biological laboratory; scientific research and development services; laboratory testing; laboratory services; testing of pharmaceuticals; analysis of human tissues for medical research; research on the subject of pharmaceuticals; research and development of vaccines and medicines; conducting early evaluations in the field of new pharmaceuticals; medical research; medical research laboratory services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; biochemical research and development; biochemical analysis; biochemistry research services; biological analysis; biomedical research services; chemical research and analysis services

Publications

History of USPTO decisions and trademark events.

51 publications found

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

08/12/2026

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

08/12/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/10/2026

ES71

TEAS SECTION 71 RECEIVED

05/01/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/21/2025

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

05/03/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

01/16/2025

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

07/10/2023

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

05/26/2023

INPC

INVALIDATION PROCESSED

05/26/2023

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

05/01/2023

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

09/01/2022

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

09/01/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/30/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/19/2022

ES75

TEAS SECTION 71 & 15 RECEIVED

03/22/2022

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

05/03/2021

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

01/28/2017

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

01/26/2017

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/26/2016

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/04/2016

FIMP

FINAL DISPOSITION PROCESSED

08/04/2016

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/03/2016

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

05/27/2016

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

05/26/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/26/2016

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

05/19/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

05/03/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/16/2016

PUBO

PUBLISHED FOR OPPOSITION

02/16/2016

GPNX

NOTIFICATION PROCESSED BY IB

02/13/2016

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/27/2016

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/27/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/27/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/11/2016

ALIE

ASSIGNED TO LIE

01/04/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/29/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/02/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/02/2015

ALIE

ASSIGNED TO LIE

11/30/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/09/2015

RFNT

REFUSAL PROCESSED BY IB

11/08/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/02/2015

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/16/2015

RFRR

REFUSAL PROCESSED BY MPU

10/16/2015

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/10/2015

CNRT

NON-FINAL ACTION WRITTEN

10/09/2015

MAFR

APPLICATION FILING RECEIPT MAILED

10/06/2015

DOCK

ASSIGNED TO EXAMINER

10/02/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/02/2015

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/01/2015

Continuous trademark protection

Get notified about every new filing that threatens CETSA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.